Philochem develops pharmaceutical products based on small organic molecules and complements the Pipeline of Philogen, which focuses on antibody-based products.



By continuing to browse or by closing this window, you accept the use of cookies.

This website or its third party tools use cookies, which are necessary to its functioning and required to achieve the purposes illustrated in the cookie policy. By closing this banner or continuing to browse, you agree to the use of cookies.

I Accept Cookie Policy